Cardiac anticoagulation therapy is a vital component in the comprehensive management of cardiovascular conditions, particularly those associated with the risk of blood clot formation. This specialized therapy aims to prevent the formation of clots within the heart's blood vessels, reducing the potential for serious complications such as strokes or heart attacks. Typically prescribed for individuals with atrial fibrillation, deep vein thrombosis, or mechanical heart valves, cardiac anticoagulation therapy involves the administration of medications like warfarin or direct oral anticoagulants. These medications work by interfering with the blood clotting process, ensuring a smoother flow of blood through the heart and vessels. While crucial for preventing thromboembolic events, the administration of cardiac anticoagulation therapy requires careful monitoring and individualized dosing to strike a delicate balance between preventing clots and minimizing the risk of bleeding complications. As advancements in medical research continue, ongoing refinements in cardiac anticoagulation therapies promise improved efficacy, reduced side effects, and better overall outcomes for individuals managing cardiovascular conditions.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation